E
Eton Pharmaceuticals, Inc. (ETON)
NGM – Real Time Price. Currency in USD
29.71
-0.13 (-0.44%)
At close: May 12, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NGM – Real Time Price. Currency in USD
29.71
-0.13 (-0.44%)
At close: May 12, 2026, 4:00 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 1.57 | 2.52 | 8.0 | |
| Quick ratio | 1.17 | 1.78 | 7.0 | |
| Debt to Equity | 1.19 | -0.80 | 6.0 | |
| Debt to Assets | 0.34 | 0.73 | 6.0 | |
| Interest coverage | 2.05 | -13.90 | 6.0 | |
| Weighted average score | 6.6 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 21M | 32M | 39M | 80M | 80M |
| Gross Profit | 14M | 21M | 23M | 43M | 43M |
| Operating Income | -8M | -1M | -2M | 72K | 72K |
| Net Income | -9M | -936K | -4M | -5M | -5M |
| EBITDA | -6M | -291K | -1M | 4M | 4M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 29.1 | 288.89 | 10 |
| Next quarter | 35.69 | 266.67 | 10 |
| Current year | 35.58 | 141.43 | 10 |
| Next year | 58.82 | 118.54 | 10 |
| Weighted average score | 10 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -5.24 | 176.96 | 25 | -198.78 | 5.5 |
| Y/Y | 82.72 | 347.99 | 350 | -1392.91 | 7.8 |
| 3y average | 59.04 | -79.71 | 49.08 | 312.34 | 7.8 |
| 5y average | 11210.79 | -101.5 | -21.75 | 243.41 | 5.5 |
| Weighted average score | 6.7 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Total debt $31.1M significantly exceeds cash reserves ($25.9M), raising financial stability concerns
Total current assets $60.6M exceed Total current liabilities $38.5M, highlighting excellent liquidity
Debt-to-equity ratio (1.2) is near the industry average, reflecting balanced leverage
Interest coverage ratio (2x) is sufficient but not particularly strong
Negative free cash flow -$11.6M limits the company's ability to reinvest or pay down debt